Stopping azithromycin mass drug administration for trachoma: A systematic review.

Stopping azithromycin mass drug administration for trachoma: A systematic review.

The World Health Organization (WHO) recommends continuing azithromycin mass drug administration (MDA) for trachoma until endemic regions drop below 5% prevalence of active trachoma in children aged 1-9 years. Azithromycin targets the ocular strains of Chlamydia trachomatis that cause trachoma. Regio...

Full description

Bibliographic Details
Main Authors: Hamidah Mahmud, Emma Landskroner, Abdou Amza, Solomon Aragie, William W Godwin, Anna de Hostos Barth, Kieran S O'Brien, Thomas M Lietman, Catherine E Oldenburg
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2021-07-01
Series:PLoS Neglected Tropical Diseases
Online Access:https://journals.plos.org/plosntds/article/file?id=10.1371/journal.pntd.0009491&type=printable

Internet

https://journals.plos.org/plosntds/article/file?id=10.1371/journal.pntd.0009491&type=printable

Similar Items